These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

341 related items for PubMed ID: 22262513

  • 1. Comparative responsiveness of the EuroQol-5D and Short Form 6D to improvement in patients with rheumatoid arthritis treated with tumor necrosis factor blockers: results of the Dutch Rheumatoid Arthritis Monitoring registry.
    Buitinga L, Braakman-Jansen LM, Taal E, Kievit W, Visser H, van Riel PL, van de Laar MA.
    Arthritis Care Res (Hoboken); 2012 Jun; 64(6):826-32. PubMed ID: 22262513
    [Abstract] [Full Text] [Related]

  • 2. The responsiveness of quality of life utilities to change in depression: a comparison of instruments (SF-6D, EQ-5D, and DFD).
    Gerhards SA, Huibers MJ, Theunissen KA, de Graaf LE, Widdershoven GA, Evers SM.
    Value Health; 2011 Jun; 14(5):732-9. PubMed ID: 21839412
    [Abstract] [Full Text] [Related]

  • 3. Rapid and sustained improvement in health-related quality of life and utility for 72 weeks in patients with ankylosing spondylitis receiving etanercept.
    Boonen A, Patel V, Traina S, Chiou CF, Maetzel A, Tsuji W.
    J Rheumatol; 2008 Apr; 35(4):662-7. PubMed ID: 18278836
    [Abstract] [Full Text] [Related]

  • 4. Identification of cutpoints for acceptable health status and important improvement in patient-reported outcomes, in rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis.
    Kvamme MK, Kristiansen IS, Lie E, Kvien TK.
    J Rheumatol; 2010 Jan; 37(1):26-31. PubMed ID: 19955045
    [Abstract] [Full Text] [Related]

  • 5. Comparison of the EQ-5D and the SF-6D utility measures in 813 patients with early arthritis: results from the ESPOIR cohort.
    Gaujoux-Viala C, Rat AC, Guillemin F, Flipo RM, Fardellone P, Bourgeois P, Fautrel B.
    J Rheumatol; 2011 Aug; 38(8):1576-84. PubMed ID: 21532054
    [Abstract] [Full Text] [Related]

  • 6. Comparison of utility measures and their relationship with other health status measures in 1041 patients with rheumatoid arthritis.
    Lillegraven S, Kristiansen IS, Kvien TK.
    Ann Rheum Dis; 2010 Oct; 69(10):1762-7. PubMed ID: 20448285
    [Abstract] [Full Text] [Related]

  • 7. A comparison of utility measurement using EQ-5D and SF-6D preference-based generic instruments in patients with rheumatoid arthritis.
    Salaffi F, Carotti M, Ciapetti A, Gasparini S, Grassi W.
    Clin Exp Rheumatol; 2011 Oct; 29(4):661-71. PubMed ID: 21813061
    [Abstract] [Full Text] [Related]

  • 8. Responsiveness of EQ-5D and SF-6D in patients with early arthritis: results from the ESPOIR cohort.
    Gaujoux-Viala C, Rat AC, Guillemin F, Flipo RM, Fardellone P, Bourgeois P, Fautrel B.
    Ann Rheum Dis; 2012 Sep; 71(9):1478-83. PubMed ID: 22419775
    [Abstract] [Full Text] [Related]

  • 9. An investigation into the empirical validity of the EQ-5D and SF-6D based on hypothetical preferences in a general population.
    Petrou S, Hockley C.
    Health Econ; 2005 Nov; 14(11):1169-89. PubMed ID: 15942981
    [Abstract] [Full Text] [Related]

  • 10. Psychometric properties of the EuroQol-5D and Short Form-6D in patients with systemic lupus erythematosus.
    Aggarwal R, Wilke CT, Pickard AS, Vats V, Mikolaitis R, Fogg L, Block JA, Jolly M.
    J Rheumatol; 2009 Jun; 36(6):1209-16. PubMed ID: 19369452
    [Abstract] [Full Text] [Related]

  • 11. Comparison of the EuroQol and short form 6D in Singapore multiethnic Asian knee osteoarthritis patients scheduled for total knee replacement.
    Xie F, Li SC, Luo N, Lo NN, Yeo SJ, Yang KY, Fong KY, Thumboo J.
    Arthritis Rheum; 2007 Aug 15; 57(6):1043-9. PubMed ID: 17665466
    [Abstract] [Full Text] [Related]

  • 12. Assessing utility values in rheumatoid arthritis: a comparison between time trade-off and the EuroQol.
    Ariza-Ariza R, Hernández-Cruz B, Carmona L, Dolores Ruiz-Montesinos M, Ballina J, Navarro-Sarabia F, Costs and Quality of Life in Rheumatoid Arthritis Study Group.
    Arthritis Rheum; 2006 Oct 15; 55(5):751-6. PubMed ID: 17013822
    [Abstract] [Full Text] [Related]

  • 13. A comparison of generic, indirect utility measures (the HUI2, HUI3, SF-6D, and the EQ-5D) and disease-specific instruments (the RAQoL and the HAQ) in rheumatoid arthritis.
    Marra CA, Woolcott JC, Kopec JA, Shojania K, Offer R, Brazier JE, Esdaile JM, Anis AH.
    Soc Sci Med; 2005 Apr 15; 60(7):1571-82. PubMed ID: 15652688
    [Abstract] [Full Text] [Related]

  • 14. Psychometric properties of the Rheumatoid Arthritis Disease Activity Index (RADAI) in a cohort of consecutive Dutch patients with RA starting anti-tumour necrosis factor treatment.
    Veehof MM, ten Klooster PM, Taal E, van Riel PL, van de Laar MA.
    Ann Rheum Dis; 2008 Jun 15; 67(6):789-93. PubMed ID: 17974597
    [Abstract] [Full Text] [Related]

  • 15. The comparative effectiveness of tumor necrosis factor-blocking agents in patients with rheumatoid arthritis and patients with ankylosing spondylitis: a six-month, longitudinal, observational, multicenter study.
    Heiberg MS, Nordvåg BY, Mikkelsen K, Rødevand E, Kaufmann C, Mowinckel P, Kvien TK.
    Arthritis Rheum; 2005 Aug 15; 52(8):2506-12. PubMed ID: 16052584
    [Abstract] [Full Text] [Related]

  • 16. The prevalence of clinical remission in RA patients treated with anti-TNF: results from the Dutch Rheumatoid Arthritis Monitoring (DREAM) registry.
    de Punder YM, Fransen J, Kievit W, Houtman PM, Visser H, van de Laar MA, van Riel PL.
    Rheumatology (Oxford); 2012 Sep 15; 51(9):1610-7. PubMed ID: 22539487
    [Abstract] [Full Text] [Related]

  • 17. An empirical evaluation of the SF-12, SF-6D, EQ-5D and Michigan Hand Outcome Questionnaire in patients with rheumatoid arthritis of the hand.
    Dritsaki M, Petrou S, Williams M, Lamb SE.
    Health Qual Life Outcomes; 2017 Jan 24; 15(1):20. PubMed ID: 28118833
    [Abstract] [Full Text] [Related]

  • 18. Comparison of internal and external responsiveness of the generic Medical Outcome Study Short Form-36 (SF-36) with disease-specific measures in rheumatoid arthritis.
    Veehof MM, ten Klooster PM, Taal E, van Riel PL, van de Laar MA.
    J Rheumatol; 2008 Apr 24; 35(4):610-7. PubMed ID: 18322989
    [Abstract] [Full Text] [Related]

  • 19. Long-term followup of health status in patients with severe rheumatoid arthritis after high-dose chemotherapy followed by autologous hematopoietic stem cell transplantation.
    Teng YK, Verburg RJ, Sont JK, van den Hout WB, Breedveld FC, van Laar JM.
    Arthritis Rheum; 2005 Aug 24; 52(8):2272-6. PubMed ID: 16052541
    [Abstract] [Full Text] [Related]

  • 20. A comparison of SF-6D and EQ-5D utility scores in a study of patients with schizophrenia.
    McCrone P, Patel A, Knapp M, Schene A, Koeter M, Amaddeo F, Ruggeri M, Giessler A, Puschner B, Thornicroft G.
    J Ment Health Policy Econ; 2009 Mar 24; 12(1):27-31. PubMed ID: 19346564
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.